Dario Neri Selected Research

Dario Neri Research Topics

Disease

195	Neoplasms (Cancer) 12/2022 - 03/2002
18	Melanoma (Melanoma, Malignant) 11/2020 - 04/2011
17	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2007
17	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 04/2010
14	Inflammation (Inflammations) 01/2021 - 04/2007
13	Teratocarcinoma 09/2018 - 07/2002
11	Necrosis 09/2021 - 01/2007
11	Arthritis (Polyarthritis) 01/2021 - 01/2007
9	Carcinoma (Carcinomatosis) 12/2020 - 04/2006
9	Lymphoma (Lymphomas) 01/2018 - 03/2009
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 09/2013
7	Leukemia 01/2021 - 09/2013
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2008
6	Rheumatoid Arthritis 01/2019 - 03/2002
6	Hematologic Neoplasms (Hematological Malignancy) 11/2017 - 06/2008
6	Kidney Neoplasms (Kidney Cancer) 01/2017 - 11/2006
5	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 01/2017
4	Hypoxia (Hypoxemia) 10/2020 - 06/2004
4	Colitis 10/2019 - 08/2015
4	Glioma (Gliomas) 06/2018 - 07/2006
4	Fibrosis (Cirrhosis) 12/2016 - 02/2010
4	Experimental Arthritis 01/2016 - 01/2007
4	Breast Neoplasms (Breast Cancer) 01/2015 - 04/2007
4	Atherosclerotic Plaque (Atheroma) 02/2011 - 12/2004
3	Fibrosarcoma 01/2017 - 04/2006
3	Disease Progression 08/2015 - 06/2013

Drug/Important Bio-Agent (IBA)

99	Proteins (Proteins, Gene)FDA Link 12/2022 - 03/2002
80	Fibronectins (Fibronectin)IBA 03/2022 - 03/2002
67	CytokinesIBA 03/2022 - 03/2002
52	AntigensIBA 11/2021 - 07/2003
48	AntibodiesIBA 01/2021 - 03/2002
34	Interleukin-2 (IL2)IBA 01/2021 - 03/2002
31	Monoclonal AntibodiesIBA 11/2020 - 12/2002
28	Pharmaceutical PreparationsIBA 01/2022 - 12/2002
26	Immunoglobulin FragmentsIBA 01/2021 - 07/2002
26	F8 monoclonal antibodyIBA 01/2021 - 06/2008
22	TenascinIBA 01/2020 - 06/2005
21	LigandsIBA 11/2021 - 12/2002
21	Biological ProductsIBA 01/2021 - 08/2005
19	Protein Isoforms (Isoforms)IBA 01/2020 - 03/2002
17	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 11/2002
15	Peptides (Polypeptides)IBA 11/2021 - 07/2002
14	Carbonic Anhydrase IXIBA 06/2021 - 08/2009
12	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 06/2003
12	Interleukin-12 (IL 12)IBA 01/2021 - 06/2003
11	Immunoglobulin G (IgG)IBA 01/2020 - 11/2002
8	Acetazolamide (Diamox)FDA LinkGeneric 10/2020 - 08/2009
8	Interleukin-4 (Interleukin 4)IBA 01/2018 - 01/2014
8	Coloring Agents (Dyes)IBA 04/2014 - 06/2005
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2007
6	Radioisotopes (Radionuclides)IBA 01/2022 - 01/2010
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 10/2008
6	CollagenIBA 01/2021 - 01/2007
6	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
6	Indicators and Reagents (Reagents)IBA 11/2020 - 08/2005
6	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 12/2011
6	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2018 - 11/2002
6	Cytotoxins (Cytolysins)IBA 01/2017 - 04/2006
5	monomethyl auristatin EIBA 01/2021 - 01/2017
5	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 08/2014
4	Fluorescein (Funduscein)FDA LinkGeneric 11/2021 - 02/2013
4	Interleukin-15 (Interleukin 15)IBA 01/2021 - 05/2007
4	Messenger RNA (mRNA)IBA 10/2020 - 06/2004
4	Glycoproteins (Glycoprotein)IBA 01/2020 - 05/2006
4	Melphalan (Alkeran)FDA LinkGeneric 01/2020 - 05/2004
4	Dextrans (Dextran)FDA Link 10/2019 - 08/2015
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2019 - 08/2015
4	Sunitinib (Sutent)FDA Link 06/2018 - 12/2010
4	DisulfidesIBA 01/2017 - 04/2014
4	DipeptidesIBA 01/2017 - 12/2016
4	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 01/2014
4	Paclitaxel (Taxol)FDA LinkGeneric 09/2014 - 04/2012
4	oncofetal fibronectinIBA 02/2012 - 04/2007
4	Biotin (Vitamin H)FDA Link 04/2011 - 04/2007
3	Extracellular Matrix ProteinsIBA 01/2022 - 05/2003
3	Chimeric Antigen ReceptorsIBA 11/2021 - 01/2020
3	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 04/2011
3	EnzymesIBA 01/2021 - 01/2017
3	Therapeutic UsesIBA 01/2021 - 06/2003
3	EpitopesIBA 10/2020 - 03/2009
3	Vascular Endothelial Growth Factor CIBA 10/2019 - 08/2010
3	AcidsIBA 02/2019 - 01/2016
3	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 12/2010
3	Bispecific AntibodiesIBA 03/2016 - 11/2012
3	Maytansine (Maitansine)IBA 11/2015 - 04/2014
3	ProteomeIBA 03/2014 - 07/2009
3	AlbuminsIBA 08/2011 - 08/2009
3	EstersIBA 07/2010 - 04/2007
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 04/2007
2	A-Form DNA (A-DNA)IBA 11/2021 - 06/2021
2	placental alkaline phosphataseIBA 11/2021 - 01/2014
2	Interleukin-9 (Interleukin 9)IBA 03/2021 - 01/2021

Therapy/Procedure

85	Therapeutics 12/2022 - 03/2002
14	Immunotherapy 01/2021 - 09/2014
12	Drug Therapy (Chemotherapy) 01/2021 - 04/2006
10	Intravenous Injections 03/2022 - 07/2002
9	Intravenous Administration 01/2021 - 01/2014
7	Radioimmunotherapy 05/2014 - 07/2006
3	Heart Transplantation (Grafting, Heart) 10/2014 - 01/2011